The medicines that prevent and treat malaria should be tailored to the diverse geographies in which they are deployed and meet the unique needs of pregnant women and the youngest patients. Take a listen to MMV’s Cristina Donini, Head of Program Leadership and Strategy and Hanu Ramachandruni, Senior Director, Pharmaceutical Development discuss the process of antimalarial development through the lens of field context and patient needs.